Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 3
1954 4
1955 5
1956 5
1957 5
1958 3
1959 3
1960 4
1961 1
1963 2
1964 3
1965 3
1966 1
1967 3
1968 1
1969 1
1971 2
1972 4
1973 3
1974 1
1975 4
1977 1
1978 1
1979 3
1980 1
1981 2
1982 1
1983 1
1984 5
1985 3
1986 5
1987 8
1988 4
1989 6
1990 3
1991 5
1992 4
1993 2
1994 8
1995 7
1996 4
1997 3
1998 4
1999 1
2000 1
2001 6
2002 3
2003 6
2004 3
2005 3
2006 3
2007 4
2008 11
2009 6
2010 8
2011 8
2012 10
2013 12
2014 12
2015 11
2016 10
2017 18
2018 10
2019 8
2020 7
2021 5
2022 5
2023 3
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

307 results

Results by year

Filters applied: . Clear all
Page 1
Tranexamic Acid to Prevent Obstetrical Hemorrhage after Cesarean Delivery.
Pacheco LD, Clifton RG, Saade GR, Weiner SJ, Parry S, Thorp JM Jr, Longo M, Salazar A, Dalton W, Tita ATN, Gyamfi-Bannerman C, Chauhan SP, Metz TD, Rood K, Rouse DJ, Bailit JL, Grobman WA, Simhan HN, Macones GA; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal–Fetal Medicine Units Network. Pacheco LD, et al. N Engl J Med. 2023 Apr 13;388(15):1365-1375. doi: 10.1056/NEJMoa2207419. N Engl J Med. 2023. PMID: 37043652 Free PMC article. Clinical Trial.
Antenatal Betamethasone for Women at Risk for Late Preterm Delivery.
Gyamfi-Bannerman C, Thom EA, Blackwell SC, Tita AT, Reddy UM, Saade GR, Rouse DJ, McKenna DS, Clark EA, Thorp JM Jr, Chien EK, Peaceman AM, Gibbs RS, Swamy GK, Norton ME, Casey BM, Caritis SN, Tolosa JE, Sorokin Y, VanDorsten JP, Jain L; NICHD Maternal–Fetal Medicine Units Network. Gyamfi-Bannerman C, et al. N Engl J Med. 2016 Apr 7;374(14):1311-20. doi: 10.1056/NEJMoa1516783. Epub 2016 Feb 4. N Engl J Med. 2016. PMID: 26842679 Free PMC article. Clinical Trial.
Fish neurotrophins and Trk receptors.
Heinrich G, Lum T. Heinrich G, et al. Int J Dev Neurosci. 2000 Feb;18(1):1-27. doi: 10.1016/s0736-5748(99)00071-4. Int J Dev Neurosci. 2000. PMID: 10708902 Review. No abstract available.
Bacitracin synthetase.
Rieder H, Heinrich G, Breuker E, Simlot MM, Pfaender P. Rieder H, et al. Among authors: heinrich g. Methods Enzymol. 1975;43:548-59. doi: 10.1016/0076-6879(75)43117-2. Methods Enzymol. 1975. PMID: 1134372 No abstract available.
INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line.
Colombo N, Gadducci A, Sehouli J, Rulli E, Mäenpää J, Sessa C, Montes A, Ottevanger NB, Berger R, Vergote I, D'Incalci M, Churruca Galaz C, Chekerov R, Nyvang GB, Riniker S, Herbertson R, Fossati R, Barretina-Ginesta MP, Deryal M, Mirza MR, Biagioli E, Iglesias M, Funari G, Romeo M, Tasca G, Pardo B, Tognon G, Rubio-Pérez MJ, DeCensi A, De Giorgi U, Zola P, Benedetti Panici P, Aglietta M, Arcangeli V, Zamagni C, Bologna A, Westermann A, Heinzelmann-Schwarz V, Tsibulak I, Wimberger P, Poveda A; INOVATYON study group. Colombo N, et al. Br J Cancer. 2023 Apr;128(8):1503-1513. doi: 10.1038/s41416-022-02108-7. Epub 2023 Feb 9. Br J Cancer. 2023. PMID: 36759720 Free PMC article. Clinical Trial.
The Endocrine Treatment Landscape for Patients with HR+ HER2- Early-stage Breast Cancer in Germany Before the Introduction of CDK4/6 Inhibitor Therapy - A Real-World Analysis.
Nabieva N, Altmann F, Apel K, Baerens DT, Beha M, Belau A, Busch S, Guth D, Heinrich G, Kreiss-Sender J, Markmann S, Olbermann A, Oskay-Özcelik G, Schuback B, Steinfeld-Birg D, Quiering C, Kiss F, Kreuzeder J, Nuti P, Schilling J. Nabieva N, et al. Among authors: heinrich g. Geburtshilfe Frauenheilkd. 2023 Jul 18;83(9):1127-1137. doi: 10.1055/a-2100-0643. eCollection 2023 Sep. Geburtshilfe Frauenheilkd. 2023. PMID: 37942358 Free PMC article.
Exposing medical students to expanding populations.
Lindenthal JJ, DeLisa JA, Heinrich GF, Calderón Gerstein WS. Lindenthal JJ, et al. Among authors: heinrich gf. Adv Med Educ Pract. 2015 Mar 19;6:177-82. doi: 10.2147/AMEP.S77894. eCollection 2015. Adv Med Educ Pract. 2015. PMID: 25834472 Free PMC article.
Long-term outcomes of a randomized, open-label, phase II study comparing cabazitaxel versus paclitaxel as neoadjuvant treatment in patients with triple-negative or luminal B/HER2-negative breast cancer (GENEVIEVE).
Meyer-Wilmes P, Huober J, Untch M, Blohmer JU, Janni W, Denkert C, Klare P, Link T, Rhiem K, Bayer C, Reinisch M, Bjelic-Radisic V, Zahm DM, Hanusch C, Solbach C, Heinrich G, Hartkopf AD, Schneeweiss A, Fasching P, Filmann N, Nekljudova V, Holtschmidt J, Stickeler E, Loibl S. Meyer-Wilmes P, et al. Among authors: heinrich g. ESMO Open. 2024 May;9(5):103009. doi: 10.1016/j.esmoop.2024.103009. Epub 2024 Apr 24. ESMO Open. 2024. PMID: 38663168 Free PMC article. Clinical Trial.
307 results